How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?-Reference-Cited by-同舟云学术

How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

Published:2017-07 Issue: Volume:262 Page:107-112
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Masana Luis^ORCID,Plana Nuria,Pérez-Calahorra Sofia,Ibarretxe Daiana,Lamiquiz-Moneo Itziar,Pedro-Botet Juan,Suárez-Tembra Manuel,Valdivielso Pedro,Ortega Emilio,Civeira Fernando

Funder

MARATO TV3

Fondo de Investigaciones Sanitarias

Instituto Investigación Sanitaria Carlos III. Madrid

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Child-parent familial hypercholesterolemia screening in primary care;Wald;N. Engl. J. Med.,2016

2. Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States national health and nutrition examination surveys (NHANES);De Ferranti;Circulation,2016

3. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology;De Backer;Atherosclerosis,2015

4. Cardiovascular disease risk associated with familial hypercholesterolemia: a systematic review of the literature;Wong;Clin. Ther.,2016

5. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: analysis of 734 French patients;Béliard;J. Clin. Lipidol.,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment target achievement in patients with familial hypercholesterolemia: A real-world descriptive study;Clinical Biochemistry;2023-10

2. Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN;Clínica e Investigación en Arteriosclerosis;2021-11

3. Implantation of a biochemical and genetic screening programme for family hypercholesterolaemia. Collaboration between the clinical laboratory and lipid units: Design of the ARIAN Project;Clínica e Investigación en Arteriosclerosis (English Edition);2021-11

4. Principales barreras en el control de las dislipemias: intolerantes;Clínica e Investigación en Arteriosclerosis;2021-05

5. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia;Nutrition, Metabolism and Cardiovascular Diseases;2021-05